The present study examined modifications of b-naphthoflavone (b-NF)-induced cytochrome P450 1A1 (CYP1A1) expression by flavonoids in mouse hepatocytes in primary culture. Some flavonoids (apigenin, chrysin, flavone, flavanone, galangin, luteolin, and naringenin) by themselves induced CYP1A1 mRNA expression, especially flavone which was even more effective than b-NF. The effect on b-NF-induced CYP1A1 mRNA expression was varied, namely additive, suppressive, or both. An additive effect was observed after combined treatment with flavanone, naringenin, and chrysin, whereas kaempferol, myricetin, and quercetin decreased CYP1A1 levels. Apigenin, chrysin, galangin, luteolin, and morin synergistically enhanced b-NF-induced CYP1A1 expression at 24 h, but considerably suppressed it at 9 h. The structure-activity relationship of flavonoids affecting CYP1A1 expression as inducers or inhibitors is discussed. The present observations suggest the need to reveal the mechanism by which CYP1A1 expression is modified by flavonoids for risk assessment, since CYP1A1 activates environmental carcinogenic polycyclic hydrocarbons and flavonoids are major constituents in food.
Flavonoids are polyphenolic secondary metabolites widely distributed in fruits, vegetables, and plant-derived beverages. Flavonoids demonstrate a wide range of biochemical and pharmacological activities including anti-oxidative, antiinflammatory, anti-platelet, anti-thrombotic, and anti-allergic effects. [1] [2] [3] [4] Flavanones, flavones, and flavonols are all flavonoids (Fig. 1 ). For example, apigenin, a flavone abundant in common fruits and vegetables, such as bell pepper, belimbi fruit, garlic, and guava, 5) has potential to be an anticancer agent.
6) It has low toxicity, no mutagenicity, and been shown to inhibit cell growth and induce apoptosis in cancer cells without affecting normal cells. 7) Kaempferol, a flavonol with -OH at the 3-position of apigenin is abundant in herbs such as Ginkgo biloba, 8) and fruits and vegetables such as onion leaves, papaya shoots, and pumpkin. 5) Kaempferol has several pharmacological effects, including anti-oxidation, anti-radical, and anti-inflammation. [9] [10] [11] Accordingly, the use of flavonoids as food supplements or therapeutic agents requires more information on safety and potential toxicity, such as influences on metabolizing enzymes, the modified expression of which can result in changes in the biological activities of xenobiotics.
The cytochrome P450 1A1 (CYP1A1) family, consisting of the structurally related isozymes CYP1A1 and CYP1A2, metabolically activates a large number of procarcinogens to form reactive intermediates that can interact with cellular nucleophiles and ultimately trigger carcinogenesis.
12) The activities of CYP1A1 and CYP1A2 are associated with various cancers. 12, 13) Therefore, modulation of the activity of CYP1A1 by dietary flavonoids may affect the metabolism of carcinogens, with implications for cancer prevention or risk assessment.
Flavonoids have been reported to inhibit CYP1A-mediated ethoxyresorufin O-deethylase (EROD) activity in rat and human liver microsomes. 14) A study using cDNA-expressed P450s to explore the effects of flavonoids on activities catalyzed by mouse CYP1A1 and CYP1A2, and human CYP1A2 15) found that some flavonoids affected mouse and human CYP1A2 differently. Moreover, flavonoids were reported to act as agonists or antagonists for the aryl hydrocarbon receptor (AhR) depending on their structure and cell context. 16) This study aimed to investigate the effects of hydroxylsubstituted flavonoids on b-naphthoflavone (b-NF)-induced CYP1A1 expression using mouse hepatocytes in primary culture to elucidate the structural features governing changes in the expression of CYP1A1.
MATERIALS AND METHODS
Chemicals Materials for culturing hepatocytes were purchased from Gibco ® Invitrogen Cell Culture (Carlsbad, CA, U.S.A.), BioWhittaker TM Cambrex Bio-Sciences (Walkerville, MD, U.S.A.), and Wako Pure Chemical (Osaka, Japan). Percoll and collagenase (Type I) were products of GE Healthcare Bio-Sciences AB (Uppsala, Sweden) and Sigma Chemical (St. Louis, MO, U.S.A.), respectively. All flavonoids (Fig.  1) were supplied by Wako Pure Chemical and Sigma Chemical. b-NF was obtained from Sigma Chemical. ReverTraAce was a product of Toyobo (Osaka, Japan). SYBR ® Green I and G-Taq Labo Pass TM were products of Lonza (Basel, Switzerland) and Hokkaido System Science (Sapporo, Japan), respectively. The TaqMan ® Gene Expression Assays and TaqMan ® Gene Expression Detection kit were products of Applied Biosystems (Branchburg, NJ, U.S.A.). The antibody against rat CYP1A1 was generously provided by Dr. Y. Funae (Osaka City University, Osaka, Japan). All other laboratory chemicals were of the highest purity available from commercial suppliers.
Preparation of Primary Cultures of Mouse Hepatocytes and Treatment C57BL/6 male mice (Sankyo Laboratories, Shizuoka, Japan) at 7 weeks of age were kept in animal room in University of Toyama. The experimental protocol of the present investigation was approved by the University's Institutional Animal Care and Use Committee in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the United States National Institutes of Health. The liver was perfused with collagenase, and viable hepatocytes were isolated by Percoll isodensity centrifugation as described. 17) Standard culture conditions were as follows: the cells were dispersed in Waymouth MB752/1 medium containing bovine serum albumin (2 g/l), insulin (0.5 mg/l), transferrin (0.5 mg/l), and selenium (0.5 mg/l), and seeded at a density of 5ϫ10 5 cells/1.5 ml/35-mm collagen-coated dish. The Waymouth medium did not contain phenol red, a pH indicator, to exclude the possibility of estrogen-like action. The hepatocytes anchored to the collagen-coated dishes within 3 h and subsequently formed a monolayer. The culture dishes were maintained at 37°C in a 5% CO 2 -humidified incubator. The medium was renewed 3 h after plating and then, 24 h later, 100 mM flavonoids and/or 10 mM b-NF were added after a change of medium. Measurements of lactate dehydrogenase activity in medium indicated it to be non-toxic at these concentrations, compared to 0.2% dimethyl sulfoxide (DMSO) as a control and 0.3% Tween 20 as a positive control (100% cytotoxicity). Total RNA was prepared from the cells at indicated times as described.
18)
Quantitative Real Time Reverse Transcription-Polymerase Chain Reactions (RT-PCR) The expression of mouse CYPs and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs was quantified by real-time RT-PCR. cDNAs were synthesized by ReverTraAce and amplified by G-Taq DNA polymerase as recommended by the manufacturers using specific TaqMan ® TAMRA Gene Expression Detection kits for Cyp1a1 in which the forward primer, reverse primer, and probe were 5Ј-GAC ATT TGA GAA GGG CCA CAT C-3Ј, 5Ј-CCA AAG AGG TCC AAA ACA ATC G-3Ј, and 5Ј-FAM-CGA GAA TGC CAA TGT CCA GCT GTC A-TAMRA-3Ј, respectively, or specific TaqMan ® Gene Expression Assays for Cyp1b1 (Mm00487229_m1), or SYBR ® Green I for GAPDH in which the forward and reverse primers were 5Ј-TCC ACT CAC GGC AAATTC AAC G-3Ј and 5Ј-TAG ACT CCA CGA CAT ACT CAG C-3Ј, respectively. 19) Real-time PCR was performed using the ABI Prism ® 7000 Sequence Detection System with ABI Prism ® 7000 SDS software. The PCR conditions were as follows: denaturation at 95°C for 15 s, and annealing and extension at 60°C for 1 min. The amplified products of CYP1A1 and CYP1B1, were detected directly by monitoring the fluorescence of the reporter dye (FAM). The amplified PCR product of GAPDH was monitored directly by measuring the increase in SYBR ® Green. Ethoxyresorufin-O-Deethylase (EROD) Assay EROD activity was determined by the method of Sakuma et al. 20) with some modifications. Briefly, the hepatocytes at 24 h or 48 h after starting treatment were incubated with 10 mM ethoxyresorufin and then a 0.4-ml aliquot of the medium was sampled at indicated times. Subsequently, the formation of resorufin was immediately analyzed by spectrofluorometry with excitation at 530 nm and emission at 585 nm.
21)

Western Blot Analysis of Microsomal Proteins
The microsomal fraction was prepared by ultracentrifugation of the 10000ϫg supernatant of the hepatocytes at 104000ϫg for 60 min at 4°C. 22) The concentration of microsomal protein was determined using bovine serum albumin as a standard. Ten micrograms of the protein was resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a Hybond-C membrane. The P450 species were detected using a rabbit polyclonal antibody against the rat CYP1A1 protein that cross-reacted with CYP1A2, followed by a biotinylated goat anti-rabbit immunoglobulin G (IgG) and biotinylated horseradish Havidin complex, and then visualized with 3,3Ј-diaminobenzidine and hydrogen peroxide.
RESULTS
Time Course of CYP1A1 and CYP1B1 Expression
Induced by b-NF in the Presence of Apigenin Expression of CYP1A1 mRNA was induced with a peak at 9 h after treatment with b-NF ( Fig. 2A) and, thereafter, decreased. In the presence of apigenin, the expression was suppressed for up to 12 h. However, thereafter, it was markedly enhanced in b-NF plus apigenin-treated hepatocytes, namely after 15 h the amount of mRNA was far greater than that in b-NFtreated cells. Induction of CYP1B1 mRNA expression was also observed with a peak at 15 h after treatment with b-NF (Fig. 2B) . Furthermore, apigenin reduced the expression of CYP1B1 for up to 9 h and after 12 h the expression was enhanced prominently as observed in the case of CYP1A1 mRNA. Apigenin did not significantly modify the expression of CYP1A2 induced by b-NF (data not shown).
Concentration-Dependent Suppression and Enhancement of Apigenin on b-NF-Inducible CYP1A1 Expression As shown in Fig. 2 , apigenin had both suppressive and enhancing effects on CYP1A1 mRNA expression after combined treatment with b-NF. Figure 3 shows the concentration-dependent impact of apigenin to be remarkable. Apigenin concentration-dependently suppressed b-NF-induced expression of CYP1A1 mRNA at 9 h, but enhanced it at 24 h.
Effect of Flavonoids on Inducible CYP1A1 Expression
Eleven flavonoids were compared in terms of their effects on CYP1A1 mRNA expression (Fig. 4) . CYP1A1 was markedly expressed after treatment with flavone, and weakly expressed after treatment with apigenin, chrysin, flavanone, galangin, luteolin, and naringenin. No significant expression of CYP1A1 was observed after treatment with kaempferol, morin, myricetin, or quercetin. The effect of these flavonoids on b-NF-induced CYP1A1 mRNA expression varied, but an additive effect was observed after combined treatment with chrysin, flavanone, or naringenin. Kaempferol, myricetin, and quercetin decreased the b-NF-inducible CYP1A1 expression. Interestingly, apigenin, galangin, luteolin and morin suppressed the b-NF-induced CYP1A1 mRNA expression at 9 h, but enhanced it at 24 h. Flavone by itself increased CYP1A1 expression depending on the treatment period, with amounts of the mRNA higher at 24 and 48 h than at 9 and 24 h, respectively. Since the expression was far greater than that after b-NF treatment, a synergistic effect was not so obvious. The amounts of CYP1A1 mRNA were consistent with those of microsomal protein (Fig. 5) .
Effect of Flavonoids on EROD Activity The expression of CYP1A1 mRNA was examined further by measuring the activity of a marker enzyme, EROD. As shown in Fig. 6A , EROD activity was observed in b-NF-treated hepatocytes in culture. Apigenin increased the b-NF-induced EROD activity, whereas kaempferol suppressed it. Despite the prominent effect of flavone on CYP1A1 mRNA expression, levels of EROD activity were low compared with those in b-NFtreated hepatocytes (Fig. 6B) .
DISCUSSION
The present investigation revealed that flavonoids greatly altered CYP1A1 mRNA expression in mouse hepatocytes in primary culture. Although several flavonoids by themselves induced CYP1A1 expression, some of them had suppressive and/or enhancing effects depending on the treatment period.
Reports on the effects of flavonoids on the expression of CYP1A1 vary. Zhang et al. 16) blamed discrepancies on the timing of observations, cell context, cell type, or concentration of the compounds. For example, the presence of apigenin and naringenin for 18 h decreased the induction of CYP1A1 expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in human HepG2 hepatoma cells. 23) Ciolino and Yeh 24) found that incubation of human MCF-7 breast cancer cells with galangin for 24 h inhibited the induction by 7,12-dimethylbenz[a]anthracene. They also reported that quercetin caused a time-and concentration-dependent increase in the expression of CYP1A1 mRNA and EROD activity, whereas kaempferol inhibited the induction by TCDD, although by itself it did not affect CYP1A1 expression. Revealing the mechanism by which flavonoids act on metabolizing enzymes is necessary for their evaluation. One reason for the different responses in different culture systems might be that characteristics have diversed after extended subculturing. Although it is not clear whether a primary culture of hepatocytes maintains completely the same expression pathway of CYP1A1, compared with the situation in vivo, it might provide more information for understanding the influence of flavonoids on the expression of CYP1A1, since the cells are freshly isolated.
Flavone is a potent CYP1A1 inducer whose activity continues for long periods. Ashida et al. 25) revealed that the 7-and 8-carbons, 1-pyran, and B-ring were regions of flavonoids with high affinity for the hydrophobic pocket of AhR, an im- portant receptor in the regulation of CYP1A1 expression. Therefore, flavone's lack of a -OH residue and planar structure might make it a strong CYP1A1 inducer. Furthermore, since flavanone has no double-bond at the 2-3 position of flavones, it might be a weak inducer as suggested by Siess et al. 26 ) -OH at the 5-and 7-positions of the A ring of 
. Effect of Flavonoids on CYP1A1 mRNA Expression in Mouse Hepatocytes
Hepatocytes at 24 h of culture were treated with 10 mM b-NF and 100 mM of either flavanone (Fn), naringenin (N), flavone (F), chrysin (Cs), apigenin (Api), luteolin (L), galangin (Ga), kaempferol (K), morin (Mo), quercetin (Q), or myricetin (My). Total RNA was prepared at 9, 24, and 48 h after the start of treatment. The expression of CYP1A1 mRNA was determined by RT-PCR and normalized to that of GAPDH mRNA. Each column represents the meanϮS.D. (nϭ4). # and ## represent a significant difference from the DMSO group at pϽ0.05 and 0.001, respectively. * and * * represent significant difference from the b-NF group at pϽ0.05 and 0.001, respectively (one-way ANOVA and Tukey post hoc test).
Fig. 5. Expression of CYP1A1 and CYP1A2 Protein in Mouse Hepatocytes
Hepatocytes were treated with 10 mM b-NF and 100 mM of either flavone (F), apigenin (Api) or kaempferol (K). Microsomal protein was prepared 24 or 48 h later, and the expression of CYP1A1 and CYP1A2 protein was analyzed as described in Materials and Methods. flavones greatly reduced, and at either of these positions on the B ring eliminated the CYP1A1-inducing effect, suggesting that these substitutions affect the three dimensional structure to diminish binding to AhR. Interestingly, the long-term effect of flavone on CYP1A1 expression is unique. For example, the expression of CYP1A1 mRNA by TCDD, a compound known not to be metabolized, shows a peak, followed by a decrease within 24 h in the present culture system. However, the possibility that the long-term effect of flavone is due to metabolites cannot be excluded, and the mechanism of induction by flavone should be studied further.
Ashida et al. 25) compared several flavonoids in ability to inhibit the TCDD-induced transformation of AhR in rat cytosol, and found that ranked as follows: quercetinϾ kaempferolϾluteolinϾapigenin. Our results show that, in terms of enhancing effect on b-NF-induced CYP1A1 expression at 24 h, the order was apigeninϾluteolinϾkaempferolϾ quercetin. Therefore, substitutions with -OH at various position determined whether the flavonoids acted as an inducer or inhibitor of CYP1A1 expression under different experimental conditions.
The flavonoids investigated here can be divided into three groups based on their effect on CYP1A1 mRNA expression: the 1st group, which includes kaempferol, myricetin, and quercetin, suppresses it all the time; the 2nd group, including chrysin, flavanone, and naringenin, additively increases it; the last group suppresses it initially, but enhances it later. A suppressive effect was observed after -OH groups were added at the 5, 7, and 4Ј-positions, but morin, which has -OH groups at the 5, 7, and 2Ј-positions, showed a different effect resembling that of the 3rd group. The difference between the 3rd group and other groups depends on the absence of -OH at the 3-position and presence of a 2,3-double bond.
Kaempferol could act as an antagonist for AhR during the induction of CYP1A1 expression by TCDD, resulting in a decrease in CYP1A1 mRNA. 27) Moreover, kaempferol and quercetin have an estrogenic effect by activating the estrogen receptor (ER) and may interact with ER-AhR crosstalk. 28, 29) Several flavonoids by themselves induce CYP1A1 mRNA expression to some degree, suggesting that they are ligands for AhR. Therefore, one possibility is that these flavoniods suppress CYP1A1 expression by competing with b-NF to bind AhR, but their suppressive effect is reduced after they have been metabolized. The controversial results regarding the effect of flavonoids on CYP1A1 expression might be due to differences in metabolizing activity in the cell culture system employed. This possibility might be proved by determining whether these flavonoids have both agonistic and antagonistic activity for AhR. Nonetheless, the mechanism of the enhancement by flavonoids is still unclear. The possibility that flavonoids influence the efficiency of mRNA processing or inhibition of mRNA turnover, or inhibit the metabolism of b-NF to continue the inducing effect should be examined. Moreover, in the present culture system, the clear difference in enhancing activity between apigenin and kaempferol, or luteolin and quercetin, could be due to the role of the 3-OH substitution in the enhanced expression of CYP1A1.
As described above, the influence of flavonoids on the activities of CYP1A1 is controversial. There are several reports of inhibitory effects on the activities of CYP1A1/2 by flavonoids. Zhai et al. 30) observed that -OH at 3,5,7-carbons played an important role in the inhibition of CYP1A1 and CYP1A2 activity. Moreover, apigenin inhibited EROD activity in human liver microsomes, 31) but, in an experiment using HepG2 cells, it increased EROD activity. 32) In addition, although kaempferol suppressed EROD activity in the present study, it had no effect on EROD activity and CYP1A1 mRNA expression in MCF-7 cells. 27) Furthermore, CanivencLavier et al. 33) reported that flavone increased EROD activity and CYP1A1 protein levels in rat liver microsomes, but to a lesser extent than b-NF. We observed EROD activity to be inhibited in the presence of flavone in mouse hepatocytes, although the induction of CYP1A1 mRNA and protein expression was prominent. The same inhibitory effect of flavone was reported in human liver microsomes by Obermeier et al. 34) Therefore, whether EROD activity is induced or inhibited might depend on the enzyme source or culture system, and these observations again indicate the necessity for a rational explanation of the discrepancy in results regarding the effects of flavonoids on metabolizing enzymes.
People are exposed to environmental carcinogens daily, some of which are activated by CYP1A1. Therefore, since we take flavonoids as dietary constituents and CYP1A1 inducers, it is necessary to reveal the mechanism responsible for the modification of CYP1A1 expression by flavonoids for risk assessment. Our findings also suggest the need for caution when using herbal medicines like flavonoids.
